Recent progress in agents targeting polo-like kinases: Promising therapeutic strategies
Author:
Funder
Shandong Province Natural Science Foundation
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference120 articles.
1. Anti-mitotic agents: are they emerging molecules for cancer treatment?;Penna;Pharmacol. Ther.,2017
2. Polo-box domain: a versatile mediator of Polo-like kinase function;Park;Cell. Mol. Life Sci.,2010
3. Targeting Polo-Like kinases: a promising therapeutic approach for cancer treatment;Liu;Transl. Oncol.,2015
4. Polo-like kinases and acute leukemia;Goroshchuk;Oncogene,2019
5. Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions;Bahassi;Exp. Biol. Med.,2011
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-07-15
2. The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysis;Heliyon;2024-04
3. Exploring Novel PLK1 Inhibitors Based on Computational Studies of 2,4-Diarylaminopyrimidine Derivatives;Letters in Drug Design & Discovery;2024-04
4. Leveraging the Fragment Molecular Orbital Method to Explore the PLK1 Kinase Binding Site and Polo-Box Domain for Potent Small-Molecule Drug Design;International Journal of Molecular Sciences;2023-10-27
5. Design, synthesis, and biological evaluation of novel molecules as potent inhibitors of PLK1;Bioorganic Chemistry;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3